InvestorsObserver
×
News Home

Is Acumen Pharmaceuticals Inc (ABOS) a Winner in the Healthcare Sector?

Thursday, May 11, 2023 01:49 PM | InvestorsObserver Analysts

Mentioned in this article

Is Acumen Pharmaceuticals Inc (ABOS) a Winner in the Healthcare Sector?

The 76 rating InvestorsObserver gives to Acumen Pharmaceuticals Inc (ABOS) stock puts it near the top of the Healthcare sector. In addition to scoring higher than 88 percent of stocks in the Healthcare sector, ABOS’s 76 overall rating means the stock scores better than 76 of all stocks.

Overall Score - 76
ABOS has an Overall Score of 76. Find out what this means to you and get the rest of the rankings on ABOS!

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 76 means the stock is more attractive than 76 percent of stocks. Not only are these scores easy to understand, but it is easy to compare stocks to each other. You can find the best stock in healthcare or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

What's Happening With Acumen Pharmaceuticals Inc Stock Today?

Acumen Pharmaceuticals Inc (ABOS) stock is trading at $5.64 as of 1:45 PM on Thursday, May 11, a loss of -$0.95, or -14.42% from the previous closing price of $6.59. The stock has traded between $5.48 and $6.59 so far today. Volume today is 268,887 compared to average volume of 222,625. Click Here to get the full Stock Report for Acumen Pharmaceuticals Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App